LYELL IMMUNOPHARMA INC

LYELNASDAQ

🏆 #3590 by market capEarnings Nov 9US Equity

$9.63▼ $0.11 (−1.13%)

🌙 After hours$9.50▼ 1.35%Regular close · extended-hours price shown

🔔

Track LYEL

Get earnings, price moves & breaking news on Telegram

Track

24h▼ 1.1%

7d▼ 8.8%

14d▼ 10.8%

30d▼ 33.0%

ytd▼ 68.5%

1y▼ 36.3%

🏦Market Cap

$225M

Small Cap

📈Revenue Growth (YoY)

-55.0%

Declining

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

8840.0x

Expensive

Otter Score

Weak

Earnings

Q3 · 2026Reported 2026-08-06

Earnings Per Share

Actual

-1.92

Expected

-1.90

miss

−1.10%

YoY +33.60%

Revenue

Actual

$4.00K

Expected

$3.63K

beat

+10.30%

YoY −50.00%

Consensus estimates

Recent quarters

Q3 2026

-1.92

miss

Q2 2026

-1.10

beat

Q1 2026

-7.68

miss

Q4 2025

-2.13

beat